Status:
UNKNOWN
Efficacy of Oral Colchicine in Prevention of Proliferative Vitreoretinopathy in Rhegmatogenous Retinal Detachment
Lead Sponsor:
Shahid Beheshti University of Medical Sciences
Conditions:
Rhegmatogenous Retinal Detachment
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
This clinical trial will test the efficacy and safety of oral colchicine in prevention of proliferative vitreoretinopathy (PVR) in cases of rhegmatogenous retinal detachment
Eligibility Criteria
Inclusion
- Rhegmatogenous retinal detachment
Exclusion
- PVR grade C
- Duration of retinal detachment ≥ one month
- History of cataract surgery
- History of RD surgery
Key Trial Info
Start Date :
March 1 2004
Trial Type :
INTERVENTIONAL
End Date :
August 1 2006
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00370201
Start Date
March 1 2004
End Date
August 1 2006
Last Update
October 9 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hamid Ahmadieh,MD
Tehran, Tehran Province, Iran, 16666